goodrx/glp 1 Get FDA-approved GLP-1s from GoodRx, lickety-split. No hidden fees, no gimmicks, and nothin' ya don't need. Learn more: https://t.co/qxqb7ifKwe Switching from a compounded to

Each medication has other, demonstrated positive health impacts (see the chart below), which can also drive the decision to use one over the other

More than 10 million claims for Ozempic were submitted in 2024, up from 524,000 in 2019 (an 82% average annual growth rate) and another 5.1 million for Mounjaro, up from 122,000 in 2022 (average annual growth of 549%)

The packaging conclusion GLP-1 drugs are often framed as a pharmaceutical breakthrough

BMC Endocr Disord (2021) 21:245

Ozempic is a GLP-1 receptor agonist that supports blood sugar control by enhancing insulin secretion and reducing appetite, often leading to weight loss

It caters particularly well to those who favor minimal injection use